A Proof of Concept Study of the Safety, Tolerability, and Efficacy of Avastin (Bevacizumab) in Patients With Chemo-naive Chronic Lymphocytic Leukemia
Clinical trial NCT00754650 · COMPLETED
Trial details
- NCT number
- NCT00754650
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2009-03-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.